|
VNDA | Vanda Pharmaceuticals Inc. |
|
|
VNDA | Vanda Pharmaceuticals Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.60 |
| Leverage | 22.16% |
| Market Cap | $ 303.2m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -66.9m |
| Margin | -30.59% |
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.